Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors

por Nishio, Makoto, Kato, Terufumi, Toyozawa, Ryo, Hida, Toyoaki
Publicado 2022

Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation

por Miyata, Kenichi, Takemoto, Ai, Okumura, Sakae, Nishio, Makoto, Fujita, Naoya
Publicado 2017

Relationship Between Pathologic T1 Categories and Pathologic Factors Affecting Prognosis in Pulmonary Adenocarcinoma

por Ninomiya, Hironori, Inamura, Kentaro, Mun, Mingyon, Nishio, Makoto, Ishikawa, Yuichi
Publicado 2022

Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based Chemotherapy

por Hayashi, Hidetoshi, Nishio, Makoto, Takahashi, Michiko, Tsuchiya, Hiroaki, Kasahara-Kiritani, Mami
Publicado 2023

A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis

por Takemoto, Ai, Okitaka, Mina, Takagi, Satoshi, Takami, Miho, Sato, Shigeo, Nishio, Makoto, Okumura, Sakae, Fujita, Naoya
Publicado 2017

Relationship of tumor PD‐L1 (CD274) expression with lower mortality in lung high‐grade neuroendocrine tumor

por Inamura, Kentaro, Yokouchi, Yusuke, Kobayashi, Maki, Ninomiya, Hironori, Sakakibara, Rie, Nishio, Makoto, Okumura, Sakae, Ishikawa, Yuichi
Publicado 2017

Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan

por Takahashi, Toshiaki, Nishio, Makoto, Nishino, Kazumi, Yoshiki, Yasumasa, Shiraiwa, Naoko, Emir, Birol, Iadeluca, Laura, Yatabe, Yasushi, Nishio, Kazuto
Publicado 2023

Distinct Characteristics of Small Cell Lung Cancer Correlate With Central or Peripheral Origin: Subtyping Based on Location and Expression of Transcription Factor TTF-1

por Miyauchi, Eisaku, Motoi, Noriko, Ono, Hiroshi, Ninomiya, Hironori, Ohyanagi, Fumiyoshi, Nishio, Makoto, Okumura, Sakae, Ichinose, Masakazu, Ishikawa, Yuichi
Publicado 2015

Erlotinib with or without bevacizumab as a first‐line therapy for patients with advanced nonsquamous epidermal growth factor receptor‐positive non‐small cell lung cancer: Explorato...

por Hosomi, Yukio, Seto, Takashi, Nishio, Makoto, Goto, Koichi, Yamamoto, Noboru, Okamoto, Isamu, Tajima, Kosei, Kajihara, Yusuke, Yamamoto, Nobuyuki
Publicado 2022

Impact of ramucirumab plus erlotinib on circulating cell-free DNA from patients with untreated metastatic non-small cell lung cancer with EGFR-activating mutations (RELAY phase 3 r...

por Nishio, Kazuto, Sakai, Kazuko, Nishio, Makoto, Seto, Takashi, Visseren-Grul, Carla, Carlsen, Michelle, Matsui, Tomoko, Enatsu, Sotaro, Nakagawa, Kazuhiko
Publicado 2023

Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study

por Seto, Takashi, Ohashi, Kadoaki, Sugawara, Shunichi, Nishio, Makoto, Takeda, Masayuki, Aoe, Keisuke, Moizumi, Sanae, Nomura, Satoshi, Tajima, Takeshi, Hida, Toyoaki
Publicado 2021

Prognostic value of (18)F‐fluoroazomycin arabinoside PET/CT in patients with advanced non‐small‐cell lung cancer

por Saga, Tsuneo, Inubushi, Masayuki, Koizumi, Mitsuru, Yoshikawa, Kyosan, Zhang, Ming‐Rong, Tanimoto, Katsuyuki, Horiike, Atsushi, Yanagitani, Noriko, Ohyanagi, Fumiyoshi, Nishio, Makoto
Publicado 2015

IMpower132: Atezolizumab plus platinum‐based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients

por Nishio, Makoto, Saito, Haruhiro, Goto, Koichi, Watanabe, Satoshi, Sueoka‐Aragane, Naoko, Okuma, Yusuke, Kasahara, Kazuo, Chikamori, Kenichi, Nakagawa, Yuki, Kawakami, Tomohisa
Publicado 2021

Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK‐rearranged non–small cell lung cancer

por Sakashita, Takuya, Yanagitani, Noriko, Koike, Sumie, Low, Siew‐Kee, Takagi, Satoshi, Baba, Satoko, Takeuchi, Kengo, Nishio, Makoto, Fujita, Naoya, Katayama, Ryohei
Publicado 2022

First-Line Lorlatinib Versus Crizotinib in ALK-Positive NSCLC: Japanese Subgroup Analysis of CROWN

por Hayashi, Hidetoshi, Teraoka, Shunsuke, Goto, Yasushi, Kumagai, Toru, Nishio, Makoto, Sugawara, Shunichi, Oizumi, Satoshi, Matsumura, Masakazu, Okura, Masayuki, Peltz, Gerson, Kato, Terufumi
Publicado 2023

Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors

por Ariyasu, Ryo, Kakuto, Sho, Miyadera, Keiki, Akita, Takahiro, Kiritani, Ayu, Tsugitomi, Ryosuke, Amino, Yoshiaki, Uchibori, Ken, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto
Publicado 2023

Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer

por Ono, Hiroshi, Motoi, Noriko, Nagano, Hiroko, Miyauchi, Eisaku, Ushijima, Masaru, Matsuura, Masaaki, Okumura, Sakae, Nishio, Makoto, Hirose, Tetsuro, Inase, Naohiko, Ishikawa, Yuichi
Publicado 2014

Interferon‐γ‐inducing Factor Gene Transfection into Lewis Lung Carcinoma Cells Reduces Tumorigenicity in vivo

por Fukumoto, Hisao, Nishio, Makoto, Nishio, Kazuto, Heike, Yuji, Arioka, Hitoshi, Kurokawa, Hirokazu, Ishida, Tomoyuki, Fukuoka, Kazuya, Nomoto, Taisuke, Ohe, Yuichiro, Saijo, Nagahiro
Publicado 1997

Characteristics of surgically resected non‐small cell lung cancer patients with post‐recurrence cure

por Sonoda, Dai, Matsuura, Yosuke, Kondo, Yasuto, Ichinose, Junji, Nakao, Masayuki, Ninomiya, Hironori, Ishikawa, Yuichi, Nishio, Makoto, Okumura, Sakae, Satoh, Yukitoshi, Mun, Mingyon
Publicado 2020

First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis

por Hotta, Katsuyuki, Nishio, Makoto, Saito, Haruhiro, Okamoto, Isamu, Nakahara, Yasuharu, Hayashi, Hidetoshi, Hayama, Manabu, Laud, Peter, Jiang, Haiyi, Paz-Ares, Luis, Azuma, Koichi
Publicado 2021